首页> 外国专利> C1-Esterase inhibitor activity determn. e.g. in plasma - by spectrophotometric analysis of chromogenic peptide substrate cleavage prods. (AT 15.04.82)

C1-Esterase inhibitor activity determn. e.g. in plasma - by spectrophotometric analysis of chromogenic peptide substrate cleavage prods. (AT 15.04.82)

机译:C1-酯酶抑制剂的活性测定。例如在血浆中-通过分光光度法分析生色肽底物裂解产物。 (AT 15.04.82)

摘要

In a new procedure for the determn. of the C1-esterase inhibitor (CEI) activity of CEI-contg. specimens by comparison of the C1-esterase activity of a standardised C1-esterase prepn. with that of the same standardised prepn. in the presence of the CEI-contg. specimen, the C1-esterase activity is determined by spectrophotometric examination of cleavage prods. of chromogenic peptide derivs. R1-A-B-NH-R (I) (where R1 is H, alkyl, a sulphonyl residue (esp. benzenesulphonyl or p-methoxy-benzenesulphonyl) or acyl (esp. alkoxycarbonyl or formyl); A is an amino acid component or di- or tripeptide residue; B is D-Arg, L-Arg, D-Lys, L-Lys, D-Orn, L-Orn, D-Tyr, L-Tyr, D-Ala or L-Ala; and NH-R is a chromophoric or fluorescent gp.). Used for determin. of C1-esterase inhibitor activity in human and animal body fluids.
机译:在一个新的确定程序中。 CEI-contg的C1-酯酶抑制剂(CEI)活性的测定。标本通过比较标准化C1酯酶prepn的C1酯酶活性。与相同的标准化制备方法相同。在存在CEI的情况下。标本中,C1酯酶活性通过分光光度法检查裂解产物来确定。发色肽的衍生。 R1-AB-NH-R(I)(其中R1是H,烷基,磺酰基残基(特别是苯磺酰基或对甲氧基-苯磺酰基)或酰基(特别是烷氧羰基或甲酰基); A是氨基酸成分或二-或三肽残基; B是D-Arg,L-Arg,D-Lys,L-Lys,D-Orn,L-Orn,D-Tyr,L-Tyr,D-Ala或L-Ala;和NH- R是发色或荧光gp。)。用于确定。和动物体液中C1-酯酶抑制剂的活性分析

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号